FDA Approves Amgen And Allergan’s KANJINTI (trastuzumab-anns), A Biosimilar To Herceptin (trastuzumab) Read more
Camargo Enhances Drug Development Services Through Acquisition of Montreal-based InSymbiosis Read more
Debiopharm and Ipsen Extend Their Strategic Decapeptyl (triptorelin) Partnership for Another 15 Years Read more
Harbour BioMed and Erasmus MC Sign MoU to Advance Next-Generation Immuno-oncology, and Immunology Drug Discovery and Clinical Development Read more